Blog Posts
Explore timely perspectives from WCG’s clinical trial operations and scientific leaders.
WCG Clinical | Insights
Recapturing the Progress Made with CTA Negotiations During the Pandemic
Blog Posts
WCG Clinical | Insights
A Look Ahead: Site Trends for 2024
Blog Posts
WCG Clinical | Insights
The Impact of Artificial Intelligence (AI) on Ethical Review by IRBs
Blog Posts
WCG Clinical | Insights
Dietary Supplements: Regulations in Research Studies and IRB Considerations
Blog Posts
WCG Clinical | Insights
Ask the Experts: What is the difference between a Risk Group and a Biosafety Level?
Blog Posts
WCG Clinical | Insights
What Information Must Be Included in the Cost Section of an Informed Consent Form?
Blog Posts
WCG Clinical | Insights
Holiday Greetings from Sam Srivastava, CEO
Blog Posts
WCG Clinical | Insights
What Is Assent, When Provided by an Adult Participant Lacking Capacity? And What Are WCG’s Expectations and the Investigator’s Responsibilities?
Blog Posts
WCG Clinical | Insights
A Review Of The Regulatory Landscape for In Vitro Gametogenesis
Blog Posts
WCG Clinical | Insights